Business | Tuesday June 3, 2014
Wockhardt's Managing Director Murtaza Khorakiwala recently told analysts that FDA had in March inspected the company's Chicago-based Morton Grove Pharmaceuticals unit, which accounts for more than 50 per cent of its sales in the United States.
www.ndtv.com/business